Nuplazid and Dementia - a phase IV clinical study of FDA data

Summary:

We study 41,162 people who have side effects when taking Nuplazid. Dementia is found, especially among people who are male, 60+ old, have been taking the drug for < 1 month, also take Seroquel and have Parkinson's disease.

The phase IV clinical study analyzes which people take Nuplazid and have Dementia. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Sep, 28, 2023

41,162 people reported to have side effects when taking Nuplazid.
Among them, 835 people (2.03%) have Dementia.

What is Nuplazid?

Nuplazid has active ingredients of pimavanserin tartrate. Currently, eHealthMe is studying from 41,167 Nuplazid users.

What is Dementia?

Dementia (madness) is found to be associated with 2,286 drugs and 1,749 conditions by eHealthMe. Currently, we are studying 41,471 people who have Dementia.

Number of Nuplazid and Dementia reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Nuplazid and have Dementia?

Check whether Dementia is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

Nuplazid side effects by duration, gender and age:

Nuplazid side effects (41,167 reports)

Dementia treatments and more:

Dementia (41,471 reports)

Common drugs associated with Dementia:

All the drugs that are associated with Dementia:

Dementia (2,286 drugs)

Common conditions associated with Dementia:

Parkinson's disease: 1,737 reports
Rheumatoid arthritis: 1,220 reports
High blood pressure: 1,056 reports
Multiple myeloma: 978 reports
Multiple sclerosis: 966 reports

All the conditions that are associated with Dementia:

Dementia (1,749 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on pimavanserin tartrate (the active ingredients of Nuplazid) and Nuplazid (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.